GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

The global hemostat and tissue sealants market is anticipated to grow at a CAGR of 8.03% between 2019 and 2027. Hemostats and tissue sealants are used post-surgery or after traumatic injuries to bind or hold external tissue (skin) as well as internal tissue (blood vessels). The hemostats and sealants market is primarily driven by the following factors:

GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

Global Hemostats and Tissue Sealants Market by Products (Topical Hemostat (Mechanical Hemostats, Active Hemostats, Flowable Hemostats) Adhesive and Tissue Sealants (Synthetic Tissue Sealant, Oxidized Regenerated Cellulose, Cyanoacrylate Adhesives, Other Synthetic Tissue Sealants) Natural Tissue Sealant( Chitin and Chitosan Based Hemostatic Agent, Other Natural Tissue Sealant, Adhesion Barrier Products & by Geography.

Request free sample

The global hemostats and tissue sealants market is anticipated to grow at a CAGR of 8.03% between 2019 and 2027. Hemostats and tissue sealants are used post-surgery or after traumatic injuries to bind or hold external tissue (skin) as well as internal tissue (blood vessels). The hemostats and sealants market is primarily driven by the following factors:

  • Increasing incidence of chronic diseases
  • Increase in aging population
  • Increase in the number of surgeries

Hemostats and Tissue Sealants Market

To know more about this report, request a free sample copy

The important drivers that are increasing the growth of the global hemostats and sealants market are the increasing cases of chronic diseases and the surge in the geriatric population. With the worldwide rise in the commonness of chronic conditions, the volume of surgical procedures is expected to increase. This is further expected to drive the demand for wound healing and sealants. Increase in aging population, which is prone to cardiovascular, neurological and musculoskeletal diseases, is expected to propel the growth of hemostasis and tissue sealing market over the forecast period.

The products of hemostats and sealants market are used extensively for various purposes. Topical hemostats are further classified into mechanical, active and flowable hemostats. Topical hemostats are generally used along with conventional treatment procedures to provide minimal tissue reactivity, quick & easy absorbability of the hemostatic agent, non-antigenicity and cost-efficiency. Mechanical hemostats perform coagulation by passively being in contact with the injured region. Active hemostats provide for controlled bleeding, better than that of the passive agents and are capable of achieving hemostasis within approximately 10 minutes. Flowable hemostats are an amalgamation of mechanical and active agents. Adhesive and tissue sealants play a prominent role in controlling blood loss during surgeries. Synthetic tissue sealants are further divided into oxidized regenerated cellulose, cyanoacrylate adhesives and other synthetic tissue sealants. Natural tissue sealants comprise of fibrin sealants, albumin sealants and collagen-based sealants.

Stringent regulations, adverse reactions and complications are the major factors hindering the growth of the hemostats and sealants market. Adverse reactions and complications can worsen a patient’s condition, so to avoid that they need to undergo an extensive agency review. It is a major constraint for the hemostasis and tissue sealing agents market.

The global hemostats and sealants market segmented into products.

Products are sub-segmented into:

  • Topical hemostat
    • Mechanical hemostats
    • Active hemostats
    • Flowable hemostats
  • Adhesive and tissue sealants
    • Synthetic tissue sealant
    • Oxidized regenerated cellulose
    • Cyanoacrylate adhesives
    • Other synthetic tissue sealants
    • Natural tissue sealant
    • Chitin and chitosan-based hemostatic agent
    • Other natural tissue sealant
    • Adhesion barrier products

This report covered the present market conditions and the growth prospects of the global hemostats and sealants market for the forecast years of 2019-2027 and considered the revenue generated through the sales of hemostats and sealants for products to calculate the market size by considering 2018 as the base year.

Geographically, the global hemostats and sealants market has been segmented on the basis of four major regions, which include:

The hemostats and sealants market in North America is expected to hold the largest share by 2027, and there are possibilities of aggressive marketing of such devices in this region. Other factors responsible for the market growth are the regular launch of new products, increasing applications of such devices in surgeries and other medical fields, and growing demand for tissue sealing agents that minimize post-operative complications and increase the speed of healing.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the hemostats and sealants market. Major factors boosting this regional market are increasing governmental initiatives that promote the use of such medical devices, growing geriatric population and increasing healthcare expenditure. Japan is estimated to be the country having the largest market share in 2018 in the Asia Pacific region. Major factors responsible for this particular market growth are growing awareness about the usage of such medical devices to avoid thrombosis and other critical post-operative complications, development of healthcare infrastructure and increasing healthcare expenditure.

The major market players of the global hemostats and sealants market are:

  • Johnson And Johnson
  • Cryolife Inc.
  • Advanced Medical Solutions (AMS) Group PLC
  • R. Bard, Inc.
  • Pfizer, Inc.

Johnson & Johnson is a worldwide producer of health care products as well as a provider of associated services. It has major operations in the Europe, Americas, Asia Pacific and Africa. The company operates through three segments: pharmaceutical, medical devices and consumer. Pfizer Inc. (Pfizer or ‘the company’), a global biopharmaceutical company, is engaged in the discovery, development and manufacture of healthcare products. The company operates in the US, Europe, Asia, Latin America, the Middle East, Africa, Australia, Canada, Japan, New Zealand and South Korea.

Key Findings of the global hemostats and sealants market:

  • Topical hemostat holds the largest market share and is anticipated to grow at the faster rate during the forecast period
  • Synthetic tissue sealants of the adhesive and tissue sealants hold the largest market share
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
      • SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASING INCIDENCE OF CHRONIC DISEASES
      • INCREASE IN AGING POPULATION
      • INCREASE IN NUMBER OF SURGERIES
    • MARKET RESTRAINTS
      • STRINGENT REGULATIONS
      • ADVERSE REACTIONS AND COMPLICATIONS
    • MARKET OPPORTUNITIES
      • USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
      • ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
    • MARKET CHALLENGES
      • LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
      • PRODUCT SIDE EFFECTS AND FDA SCRUTINY
  1. MARKET BY PRODUCTS
    • TOPICAL HEMOSTAT
      • MECHANICAL HEMOSTATS
      • ACTIVE HEMOSTATS
      • FLOWABLE HEMOSTATS
    • ADHESIVE AND TISSUE SEALANTS
      • SYNTHETIC TISSUE SEALANT
        • OXIDIZED REGENERATED CELLULOSE
        • CYANOACRYLATE ADHESIVES
        • OTHER SYNTHETIC TISSUE SEALANTS
      • NATURAL TISSUE SEALANT
        • CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
        • OTHER NATURAL TISSUE SEALANT
      • ADHESION BARRIER PRODUCTS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SCOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
      • POLITICAL & LEGAL
      • ECONOMIC
      • TECHNOLOGICAL
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • BAXTER INTERNATIONAL INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BRAUN MELSUNGEN AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • COHERA MEDICAL INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • R. BARD, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CRYOLIFE INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • CSL BEHRING
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • INTEGRA LIFESCIENCES CORP
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JOHNSON AND JOHNSON
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MEDTRONIC PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SMITH AND NEPHEW PLC
        • MARKET OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • ZIMMER BIOMET HOLDINGS INC
        • MARKET OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE 1       GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2       GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 3       GLOBAL TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 4       GLOBAL TOPICAL HEMOSTAT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5       GLOBAL MECHANICAL HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6       GLOBAL ACTIVE HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7       GLOBAL FLOWABLE HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8       GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 9       GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10     GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11     GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 12     GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13     GLOBAL CYANOACRYLATE ADHESIVES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14     GLOBAL OTHER SYNTHETIC TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15     GLOBAL NATURAL TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16     GLOBAL NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 17     GLOBAL CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18     GLOBAL OTHER NATURAL TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19     GLOBAL ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)

TABLE 20     GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 21     NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 22     EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 23     ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 24     REST OF THE WORLD HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 25     HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)

TABLE 26     TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)

LIST OF FIGURES

FIGURE 1     PROCESS OF COAGULATION

FIGURE 2     GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2018-2026 ($ MILLION)

FIGURE 3     GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE 4     GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)

FIGURE 5     GLOBAL TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)

FIGURE 6     GLOBAL TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)

FIGURE 7     GLOBAL TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)

FIGURE 8     GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)

FIGURE 9     GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)

FIGURE 17   PORTER’S FIVE FORCE MODEL

FIGURE 18   GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 19   THE UNITED STATES HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 20   CANADA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 21   THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 22   GERMANY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 23   FRANCE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 24   ITALY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 25   SPAIN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 26   REST OF EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 27   JAPAN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 28   CHINA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 29   INDIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 30   AUSTRALIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 31   SOUTH KOREA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 32   REST OF ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 33   LATIN AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 34   MIDDLE EAST AND AFRICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

  1. MARKET BY PRODUCTS
    • TOPICAL HEMOSTAT
      • MECHANICAL HEMOSTATS
      • ACTIVE HEMOSTATS
      • FLOWABLE HEMOSTATS
    • ADHESIVE AND TISSUE SEALANTS
      • SYNTHETIC TISSUE SEALANT
        • OXIDIZED REGENERATED CELLULOSE
        • CYANOACRYLATE ADHESIVES
        • OTHER SYNTHETIC TISSUE SEALANTS
      • NATURAL TISSUE SEALANT
        • CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
        • OTHER NATURAL TISSUE SEALANT
        • ADHESION BARRIER PRODUCTS
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now